Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

SAB Biotherapeutics, Inc. - Common Stock (NQ:SABS)

3.180 -0.070 (-2.15%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 79,526
Open 3.200
Bid (Size) 2.850 (900)
Ask (Size) 3.150 (8,000)
Prev. Close 3.250
Today's Range 3.135 - 3.340
52wk Range 1.000 - 6.600
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142
From SAB Biotherapeutics, Inc.
Via GlobeNewswire
SAB BIO to Participate in Upcoming Investor Conferences
From SAB Biotherapeutics, Inc.
Via GlobeNewswire

Performance

YTD
-14.3%
-14.3%
1 Month
+38.9%
+38.9%
3 Month
+45.2%
+45.2%
6 Month
+88.2%
+88.2%
1 Year
-23.2%
-23.2%

More News

Read More
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Why Is SAB BIO Stock Trading Lower On Tuesday?
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Top movers in Friday's session
Via Chartmill
Which stocks are gapping on Friday?
Via Chartmill
SAB BIO Highlights Data in Multiple Presentations at EASD
From SAB Biotherapeutics, Inc.
Via GlobeNewswire
SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes
From SAB Biotherapeutics, Inc.
Via GlobeNewswire
Which stocks are moving before the opening bell on Wednesday?
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
SAB BIO Reports Second Quarter Financial Results and Highlights Company Updates
From SAB Biotherapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
SAB BIO Announces Oversubscribed $175 Million Private Placement
From SAB Biotherapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Gold Gains 1%; Boeing Shares Rise Following Q4 Results
Via Benzinga
Nasdaq Surges More Than 300 Points; Lockheed Martin Shares Dip After Q4 Results
Via Benzinga
SAB BIO Announces Q1 2025 Financial Results and Provides Company Updates
From SAB Biotherapeutics, Inc.
Via GlobeNewswire
SAB BIO Reports Full Year 2024 Operating and Financial Results
From SAB Biotherapeutics, Inc.
Via GlobeNewswire
SAB BIO to Participate in Upcoming Investor Conferences
From SAB Biotherapeutics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is SAB Biotherapeutics, Inc. - Common Stock publicly traded?
Yes, SAB Biotherapeutics, Inc. - Common Stock is publicly traded.
What exchange does SAB Biotherapeutics, Inc. - Common Stock trade on?
SAB Biotherapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for SAB Biotherapeutics, Inc. - Common Stock?
The ticker symbol for SAB Biotherapeutics, Inc. - Common Stock is SABS on the Nasdaq Stock Market
What is the current price of SAB Biotherapeutics, Inc. - Common Stock?
The current price of SAB Biotherapeutics, Inc. - Common Stock is 3.180
When was SAB Biotherapeutics, Inc. - Common Stock last traded?
The last trade of SAB Biotherapeutics, Inc. - Common Stock was at 11/05/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.